ClinicalTrials.gg
Sign In
Status unknownNCT04737083Updated Feb 3, 2021

CGH Array in Bilateral Clubfoot

An observational study in Clubfoot and Prenatal Disorder, sponsored by Central Hospital, Nancy, France. Status unknown. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-03.

Sponsored by Central Hospital, Nancy, France · Observational

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
50
Ages
18 Years and older
Sex
Female
01

Study summary

In prenatal diagnosis of isolated bilateral clubfoot our team propose genetic analysis: a CGH-array. We want to study the rate of aberrations in these cases.

02

Conditions studied

  • Clubfoot
  • Prenatal Disorder

Browse trials for

03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's planned enrollment of 50 is close to the median of 55 across 27 observational studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Browse Central Hospital, Nancy, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women who had their follow-up in our team with a prenatal diagnosis of bilateral clubfoot in their fetus.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant women
  • fetus with isolated bilateral clubfoot

Exclusion criteria

Exclusion Criteria:

  • no
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • clubfoot fetuses

    Genetic: CGH array

Interventions

  • GeneticCGH array

    a CGH array is systematically offer to women when the fetus show bilateral clubfoot during prenatal ultrasound screening

06

What researchers measure

Primary outcomes

  1. rate of abnormal CGH-array in the population

    Time frame: 9 months

Secondary outcomes

  1. type of abnormalities in CGH-array study

    Time frame: 9 months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2021; primary completion for Feb 2021, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 25, 2021
First posted
Feb 3, 2021
StartEst.
Jan 31, 2021
Primary completionEst.
Feb 15, 2021
CompletionEst.
Nov 30, 2021
Last update
Feb 3, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 3, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04737083
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Matthieu DAP (medical doctor (MD), Central Hospital, Nancy, France) — Principal investigator
First posted
Feb 3, 2021
Start date
Jan 31, 2021 (estimated)
Primary completion
Feb 15, 2021 (estimated)
Completion
Nov 30, 2021 (estimated)
Last update
Feb 3, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Clubfoot →

Other studies from this sponsor

Central Hospital, Nancy, France →

Start the discussion